Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: georgiabiotech	7/8/2007 9:50:21 AM
	Read Replies (2) of 10280

Seprocor Gurus Robohogs Rocky ? I here Sanofi's Ambian CR will go generic in October 2007. Is this true or will Sanofi be able to delay it. This will certainly cause Ambian and Ambian CR generics to be 1st tier with formularies leaving Lunesta as 2nd or 3rd tier. But also Sanofi will no longer be detailing much to doctors offices. If Sepracor is skillful in pricing Lunesta to insurances and managed care this could even be a good thing and increase the market share of Lunesta. Right now any marketing change by Sanofi for Ambien Cr and vs versa for Seprecors Lunesta causes a similiar response from the other company. This may allow Sepracor to have more freedom to make changes in their marketing plans. What are your thoughts? Will generic Ambian Cr help or hurt Sepracor? Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next